14 March 2017
Virginia
Reporter: Barney Dixon
PTAB upholds Acorda patents
Hedge fund manager Kyle Bass has lost a US Patent Trial and Appeal Board (PTAB) inter-partes review that sought to invalidate four patents belonging to Acorda Therapeutics.

The patents relate to Acorda’s Ampyra drug, which is aimed at improving walking for adults with multiple sclerosis.

Bass filed the claim through his Coalition for Affordable Drugs, and argued that all four patents should be held invalid as unpatentable.

But in its 9 March decision, the PTAB said that it was “not persuaded” by Bass’s arguments and he had not “demonstrated by a preponderance of evidence the challenged claims are unpatentable on the instituted grounds”.

Ron Cohen, president and CEO of Acorda, said: “The court decision reflects the merits of the case we presented and the validity and strength of our intellectual property for Ampyra.”

“Medical innovation depends on the recognition of valid intellectual property claims.”

He added: “[We] will continue to defend the validity of our intellectual property rights for Ampyra.”

These four patents, as well as another relating to Ampyra, have also been challenged in the US District Court for the District of Delaware, but the court has yet to issue its decision.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
TurboPatent launches automated patent prosecution tool
28 June 2017 | Seattle | Reporter: Barney Dixon
TurboPatent has released a new tool aimed at automating and streamlining patent prosecution using artificial intelligence
UPC preparatory committee eyes new start date
28 June 2017 | Brussels | Reporter: Barney Dixon
Despite uncertainty surrounding the Unified Patent Court, its preparatory committee remains hopeful for an early 2018 launch date
Haley joins Ropes & Gray patent spin off
28 June 2017 | New York | Reporter: Barney Dixon
Ropes & Gray reveals the branding of its new patent prosecution business, following the appointment of James Haley as a name partner
Qualcomm denied motion to dismiss FTC case
28 June 2017 | California | Reporter: Barney Dixon
Qualcomm has been denied a motion to dismiss the US Federal Trade Commission’s complaint over its licensing of standard-essential patents
Poly Medicure wins European patent challenge
27 June 2017 | Munich | Reporter: Barney Dixon
Indian medical device manufacturer Poly Medicure has beaten UK-based rival B Braun in a patent dispute at the European Patent Office
UPC order reaches UK parliament
26 June 2017 | London | Reporter: Barney Dixon
The UPC is continuing its passage through the UK parliament after a tumultuous election and the recent Conservative-DUP deal
BBVA launches global patent office
26 June 2017 | Bilbao | Reporter: Barney Dixon
Spanish Bank BBVA has created a global patent office to coordinate its intellectual property protection efforts